Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yanling Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4122-4444; OpenAlex author ID A5078531189. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 4

  1. Reversal of KRAS G12D inhibitor resistance by nimotuzumab via MEK/ERK-mediated unfolded protein response in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218684↗
  2. The Role of Bile Acids in Pancreatic Cancer. Co-author DOI 10.2174/0115680096281168231215060301↗
  3. Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients. Co-author DOI 10.1049/syb2.12068↗
  4. Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Co-author DOI 10.1155/2022/5634887↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengbai Xue · 4 shared papers, 2022–2026 · strength 0.83
  2. Jiujie Cui · 4 shared papers, 2022–2026 · strength 0.83
  3. Xiaofei Zhang · 3 shared papers, 2022–2024 · strength 0.50
  4. Tiebo Mao · 3 shared papers, 2022–2024 · strength 0.50
  5. Liwei Wang · 2 shared papers, 2022–2026 · strength 0.46
  6. Liwei Wang · 2 shared papers, 2023–2024 · strength 0.37
  7. Weiyu Ge · 2 shared papers, 2022–2023 · strength 0.29
  8. Jiayu Yao · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.